Naphazoline-DF 0,05% 10 ml nasal spray
- $3.20
The instruction for medical use
of NAFAZOLIN-DF medicine
the Trade name
of Nafazolin-DF
the International unlicensed
name Naphazoline Dosage Form
of 0.05% spray
Structure
of 10 ml of drug, nasal on 10 ml, contain
active agent – naphazoline of nitrate of 5.0 mg
excipients - boric acid, water
the Transparent colourless or slightly yellowish liquid purified the Description.
Pharmacotherapeutic group
Drugs for treatment of diseases of a respiratory system. Nasal drugs. Antikongestanta and other nasal drugs for topical administration. Sympathomimetics. Naphazoline.
The ATX R01AA08 code
the Pharmacological
Pharmacokinetics Therapeutic Effect properties of naphazoline develops in 5 minutes after injection of drug and proceeds till 8 o'clock. At topical administration, naphazoline can be soaked up in a system blood stream and have systemic action.
Pharmacodynamics
Alpha adrenomimetik. Naphazoline is a sympathomimetic with direct promoting effect on alfa2-adrenoceptors. Owing to vasoconstrictive action puffiness, hyperaemia, exudation decreases. At intranasal use, naphazoline promotes simplification of nasal breath in rhinitises. Promotes opening and expansion of entrance channels of adnexal bosoms of a nose and release of Eustachian tubes. It promotes outflow of a secret and prevents sedimentation of bacteria on mucous a nose.
Indications
- acute rhinitis
- hay cold
- hyperaemia and puffiness of mucous membranes of upper airways after operations
- a rinoskopiya
the Route of administration and
Intranazalno's doses.
Naphazoline – DF, 0.05% nasal apply spray at children:
- from 2 to 6 years – on the 1st injection of spray in each nasal course 1-2 times a day,
- from 6 to 15 years – on the 1st injection of spray in each nasal course 3 times a day.
Course of treatment of 5-7 days. The repeated course of treatment is appointed by the doctor.
Side effects
- irritation of a mucous membrane
- the increased arterial blood pressure, tachycardia
- nausea, a headache
- a reactive hyperemia of a mucous membrane
- at use more than 1 week – hypostasis of a mucous membrane, atrophic rhinitis
of the Contraindication
- hypersensitivity to drug components
- an arterial hypertension, tachycardia, the profound atherosclerosis
- a serious illness of eyes
- a hyper thyroidism
- diabetes
- chronic rhinitis
- a concomitant use of inhibitors of a monoaminooxidase and the period up to 14 days after the end of their use
- children's age up to 2 years
Medicinal interactions
Drug slows down absorption of mestnoanesteziruyushchy means (extends their action when carrying out surface anesthesia).
It is incompatible with monoaminooxidase inhibitors.
The special
instructions Nafazolin-DF with care it is applied at persons with labile arterial blood pressure.
Use in pediatrics
At strict observance of the recommended mode of dosing, routes of administration (intranasal introduction) and use duration (no more than 5-7 days) the collateral and undesirable phenomena meet seldom.
Overdose
Symptoms - decrease in body temperature, bradycardia, arterial hypertension.
Treatment is symptomatic.
A release form
On 10 ml in polypropylene bottles with a cover spray and a protective cap. On each bottle paste the label. On one bottle together with the instruction for medical use in the state and Russian languages place in a pack cardboard.
To Store storage conditions in the place protected from light, at a temperature from 18 °C to 25 °C.
To store out of children's reach!
3 years
not to apply a period of storage after an expiration date.
Prescription status
Without prescription
the Producer/packer
of DOSFARM LLP, Kazakhstan, 050034, Almaty, Chaplygin St., 3, ph.: (727) 253-03-88
Owner of the registration certificate
of DOSFARM LLP, Kazakhstan, 050034, Almaty, st. Chaplygina, 3
Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products
of DOSFARM LLP, Kazakhstan, 050034, Almaty, Chaplygin St., 3, ph./fax: (727) 253-07-07, 253-03-88, el. address: dospharm@dospharm.kz
of NAFAZOLIN-DF medicine
the Trade name
of Nafazolin-DF
the International unlicensed
name Naphazoline Dosage Form
of 0.05% spray
Structure
of 10 ml of drug, nasal on 10 ml, contain
active agent – naphazoline of nitrate of 5.0 mg
excipients - boric acid, water
the Transparent colourless or slightly yellowish liquid purified the Description.
Pharmacotherapeutic group
Drugs for treatment of diseases of a respiratory system. Nasal drugs. Antikongestanta and other nasal drugs for topical administration. Sympathomimetics. Naphazoline.
The ATX R01AA08 code
the Pharmacological
Pharmacokinetics Therapeutic Effect properties of naphazoline develops in 5 minutes after injection of drug and proceeds till 8 o'clock. At topical administration, naphazoline can be soaked up in a system blood stream and have systemic action.
Pharmacodynamics
Alpha adrenomimetik. Naphazoline is a sympathomimetic with direct promoting effect on alfa2-adrenoceptors. Owing to vasoconstrictive action puffiness, hyperaemia, exudation decreases. At intranasal use, naphazoline promotes simplification of nasal breath in rhinitises. Promotes opening and expansion of entrance channels of adnexal bosoms of a nose and release of Eustachian tubes. It promotes outflow of a secret and prevents sedimentation of bacteria on mucous a nose.
Indications
- acute rhinitis
- hay cold
- hyperaemia and puffiness of mucous membranes of upper airways after operations
- a rinoskopiya
the Route of administration and
Intranazalno's doses.
Naphazoline – DF, 0.05% nasal apply spray at children:
- from 2 to 6 years – on the 1st injection of spray in each nasal course 1-2 times a day,
- from 6 to 15 years – on the 1st injection of spray in each nasal course 3 times a day.
Course of treatment of 5-7 days. The repeated course of treatment is appointed by the doctor.
Side effects
- irritation of a mucous membrane
- the increased arterial blood pressure, tachycardia
- nausea, a headache
- a reactive hyperemia of a mucous membrane
- at use more than 1 week – hypostasis of a mucous membrane, atrophic rhinitis
of the Contraindication
- hypersensitivity to drug components
- an arterial hypertension, tachycardia, the profound atherosclerosis
- a serious illness of eyes
- a hyper thyroidism
- diabetes
- chronic rhinitis
- a concomitant use of inhibitors of a monoaminooxidase and the period up to 14 days after the end of their use
- children's age up to 2 years
Medicinal interactions
Drug slows down absorption of mestnoanesteziruyushchy means (extends their action when carrying out surface anesthesia).
It is incompatible with monoaminooxidase inhibitors.
The special
instructions Nafazolin-DF with care it is applied at persons with labile arterial blood pressure.
Use in pediatrics
At strict observance of the recommended mode of dosing, routes of administration (intranasal introduction) and use duration (no more than 5-7 days) the collateral and undesirable phenomena meet seldom.
Overdose
Symptoms - decrease in body temperature, bradycardia, arterial hypertension.
Treatment is symptomatic.
A release form
On 10 ml in polypropylene bottles with a cover spray and a protective cap. On each bottle paste the label. On one bottle together with the instruction for medical use in the state and Russian languages place in a pack cardboard.
To Store storage conditions in the place protected from light, at a temperature from 18 °C to 25 °C.
To store out of children's reach!
3 years
not to apply a period of storage after an expiration date.
Prescription status
Without prescription
the Producer/packer
of DOSFARM LLP, Kazakhstan, 050034, Almaty, Chaplygin St., 3, ph.: (727) 253-03-88
Owner of the registration certificate
of DOSFARM LLP, Kazakhstan, 050034, Almaty, st. Chaplygina, 3
Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products
of DOSFARM LLP, Kazakhstan, 050034, Almaty, Chaplygin St., 3, ph./fax: (727) 253-07-07, 253-03-88, el. address: dospharm@dospharm.kz
Related Products
